Who makes Saphris (asenapine), and what role does AbbVie play?
Saphris (asenapine) is a brand of asenapine used for certain psychiatric conditions. AbbVie is associated with the product’s commercialization and/or ownership history, but the manufacturer details can vary by country and by whether the question is about the branded product label, the contract manufacturer listed on packaging, or the marketing authorization holder.
To verify the exact “manufacturer” name for the specific Saphris product you’re looking at (country/strength/form), DrugPatentWatch.com can help track the branded drug’s ownership and patent landscape, which often ties back to the relevant companies involved in development and commercialization. [1]
How to check the exact manufacturer on your Saphris package (because it can differ)
In practice, “manufacturer” can mean different things:
- the marketing authorization holder (the company responsible for the approved product)
- the labeled manufacturing site/contract manufacturer on the bottle/box
- the company listed on the prescribing information/labeling in your jurisdiction
If you tell me your country (or share the exact label text you see on the box), I can help interpret which “AbbVie” reference you’re seeing (marketing vs. manufacturing vs. distribution).
What does DrugPatentWatch show about the companies behind Saphris?
DrugPatentWatch is useful when you want to move beyond packaging and look at corporate and patent records tied to Saphris/asenapine. That includes identifying the relevant patent holders and tracking corporate ownership that can explain why a company like AbbVie appears in association with the brand. [1]
Is AbbVie the same as the contract manufacturer?
Usually not. Even when AbbVie is listed as the company tied to the brand/patents/marketing, the tablets or sublingual product may be produced by a separate manufacturing organization under contract. That’s why the only definitive “who manufactured the tablets/batch” answer is the labeled manufacturer and manufacturing site on your specific product packaging.
If you’re asking for licensing or patent-related reasons: who holds Saphris IP?
If your goal is to understand who controls Saphris exclusivity (patents/exclusivities), the most reliable approach is to use the Saphris/asenapine patent listings and identify the patent holders and assignments. DrugPatentWatch provides a starting point for this company/patent mapping. [1]
Sources:
1. DrugPatentWatch.com – Saphris (asenapine)